Washington DC, May 22 -- A press release from the US House Select Committee on China said that Chairman John Moolenaar has asked US Treasury Secretary Scott Bessent, through a letter, to classify biotechnology as a prohibited technology under the proposed COINS Act of 2025.

The letter warned that the US is "engaged in a fierce biotechnology competition with the PRC", where medical innovation is central to national and economic security. It also stated that China is pursuing a "deliberate, state-directed strategy to dominate global biotechnology", including drug development, biologics manufacturing, and clinical R&D.

The press release further highlighted the content of the letter.

"The United States is in a fierce biotechnology competit...